GPR87 exhibits dual roles in tumor progression and glycolysis: it acts as an oncogene in melanoma by promoting glycolysis and suppressing immune responses through AKT/LDHA pathway activation25, while functioning as a tumor suppressor in prostate cancer by inhibiting glycolysis26. Here, LDHA is linked to neoplasm.